chr10-110581915-C-CTT

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_005445.4(SMC3):​c.548-5_548-4dupTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0456 in 1,610,522 control chromosomes in the GnomAD database, including 1,987 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.059 ( 349 hom., cov: 31)
Exomes 𝑓: 0.044 ( 1638 hom. )

Consequence

SMC3
NM_005445.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.55
Variant links:
Genes affected
SMC3 (HGNC:2468): (structural maintenance of chromosomes 3) This gene belongs to the SMC3 subfamily of SMC proteins. The encoded protein occurs in certain cell types as either an intracellular, nuclear protein or a secreted protein. The nuclear form, known as structural maintenance of chromosomes 3, is a component of the multimeric cohesin complex that holds together sister chromatids during mitosis, enabling proper chromosome segregation. Post-translational modification of the encoded protein by the addition of chondroitin sulfate chains gives rise to the secreted proteoglycan bamacan, an abundant basement membrane protein. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 10-110581915-C-CTT is Benign according to our data. Variant chr10-110581915-C-CTT is described in ClinVar as [Likely_benign]. Clinvar id is 159989.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMC3NM_005445.4 linkc.548-5_548-4dupTT splice_region_variant, intron_variant Intron 8 of 28 ENST00000361804.5 NP_005436.1 Q9UQE7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMC3ENST00000361804.5 linkc.548-8_548-7insTT splice_region_variant, intron_variant Intron 8 of 28 1 NM_005445.4 ENSP00000354720.5 Q9UQE7

Frequencies

GnomAD3 genomes
AF:
0.0592
AC:
8995
AN:
152064
Hom.:
348
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.106
Gnomad AMI
AF:
0.0329
Gnomad AMR
AF:
0.0406
Gnomad ASJ
AF:
0.0435
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0363
Gnomad FIN
AF:
0.0503
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0434
Gnomad OTH
AF:
0.0651
GnomAD2 exomes
AF:
0.0422
AC:
10565
AN:
250438
AF XY:
0.0424
show subpopulations
Gnomad AFR exome
AF:
0.105
Gnomad AMR exome
AF:
0.0273
Gnomad ASJ exome
AF:
0.0416
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.0480
Gnomad NFE exome
AF:
0.0449
Gnomad OTH exome
AF:
0.0502
GnomAD4 exome
AF:
0.0442
AC:
64512
AN:
1458340
Hom.:
1638
Cov.:
31
AF XY:
0.0440
AC XY:
31927
AN XY:
725718
show subpopulations
Gnomad4 AFR exome
AF:
0.109
AC:
3653
AN:
33392
Gnomad4 AMR exome
AF:
0.0295
AC:
1317
AN:
44712
Gnomad4 ASJ exome
AF:
0.0403
AC:
1053
AN:
26106
Gnomad4 EAS exome
AF:
0.000151
AC:
6
AN:
39608
Gnomad4 SAS exome
AF:
0.0378
AC:
3255
AN:
86174
Gnomad4 FIN exome
AF:
0.0483
AC:
2576
AN:
53320
Gnomad4 NFE exome
AF:
0.0445
AC:
49315
AN:
1108992
Gnomad4 Remaining exome
AF:
0.0479
AC:
2885
AN:
60276
Heterozygous variant carriers
0
2720
5440
8161
10881
13601
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
1864
3728
5592
7456
9320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0592
AC:
9007
AN:
152182
Hom.:
349
Cov.:
31
AF XY:
0.0584
AC XY:
4343
AN XY:
74418
show subpopulations
Gnomad4 AFR
AF:
0.106
AC:
0.105773
AN:
0.105773
Gnomad4 AMR
AF:
0.0406
AC:
0.04056
AN:
0.04056
Gnomad4 ASJ
AF:
0.0435
AC:
0.0434908
AN:
0.0434908
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.0365
AC:
0.0364994
AN:
0.0364994
Gnomad4 FIN
AF:
0.0503
AC:
0.05034
AN:
0.05034
Gnomad4 NFE
AF:
0.0434
AC:
0.0433971
AN:
0.0433971
Gnomad4 OTH
AF:
0.0644
AC:
0.0643939
AN:
0.0643939
Heterozygous variant carriers
0
436
873
1309
1746
2182
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0497
Hom.:
48
Bravo
AF:
0.0601
Asia WGS
AF:
0.0230
AC:
80
AN:
3476
EpiCase
AF:
0.0454
EpiControl
AF:
0.0445

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 02, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 02, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 05, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Cornelia de Lange syndrome 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

De Lange syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199906378; hg19: chr10-112341673; API